Cancer
Symptoms Partnering 2007-2013
The
Cancer Symptoms Partnering 2007-2013 report provides understanding and access
to the cancer symptoms partnering deals and agreements entered into by the
worlds leading healthcare companies.
- Trends in solid
tumor cancer partnering deals
- Top solid tumor
cancer deals by value
- Deals listed by
company A-Z, industry sector, stage of development, technology type
To check out the complete table of
contents, visit:
http://www.marketresearchreports.biz/analysis-details/cancer-symptoms-partnering-2007-2013
The
Solid Tumor Cancer Partnering 2007-2013 provides understanding and access to
the solid tumor cancer partnering deals and agreements entered into by the
worlds leading healthcare companies.
This
report provides details of thelatest cancer symptoms agreements announced in
the healthcare sectors, covering:
- Symptoms
- Oral mucositis
- Cancer pain
- Bone
- Neuropathic
- Muscular
- Lymphoedema
- Alopecia
- Cachexia
- Ulcers
- Dysphagia
- Tiredness
- Weight Loss
- Nausea
- Vomiting
- Chemotherapy
- Radiotherapy
The
report provides an analysis of cancer symptoms partnering deals. The majority
of deals are discovery or development stage whereby the licensee obtains a
right or an option right to license the licensors cancer symptoms technology.
These deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.
Understanding
the flexibility of a prospective partner’s negotiated deals terms provides
critical insight into the negotiation process in terms of what you can expect to
achieve during the negotiation of terms. Whilst many smaller companies will be
seeking details of the payments clauses, the devil is in the detail in terms of
how payments are triggered – contract documents provide this insight where
press releases do not.
This
data driven report contains over 130 links to online copies of actual cancer
symptoms deals and contract documents as submitted to the Securities Exchange
Commission by companies and their partners, where available. Contract documents
provide the answers to numerous questions about a prospective partner’s
flexibility on a wide range of important issues, many of which will have a
significant impact on each party’s ability to derive value from the deal.
The
initial chapters of this report provide an orientation of cancer symptoms
partnering trends.
Chapter
1
provides an introduction to the report, whilst
Chapter
2
provides an overview of the trends in cancer symptoms partnering since 2007,
including a summary of deals by industry sector, stage of development, deal
type, and technology type. Numerous tables provide outline financial trends.
Chapter
3
provides an overview of the leading cancer symptoms deals since 2007. Deals are
listed by headline value, signed by bigpharma, most active of all pharma. Where
the deal has an agreement contract published at the SEC a link provides online
access to the contract.
Chapter
4
provides a comprehensive directory of cancer symptoms partnering deals signed
and announced since 2007. The chapter is organized by company A-Z, stage of
development at signing, deal type (collaborative R&D, co-promotion,
licensing etc), and technology type. Each deal title links via Weblink to an
online version of the deal record, and where available the contract document,
providing easy access to each contract document on demand.
In
conclusion, this report provides everything a prospective dealmaker needs to
know about partnering in the research, development and commercialization of
solid tumor cancer technologies and products.
Report
scope
Cancer
Symptoms Partnering 2007-2013 is intended to provide the reader with an
in-depth understanding and access to cancer symptoms trends and structure of
deals entered into by leading companies worldwide.
This
data driven report includes:
- Trends in cancer
symptoms dealmaking in the biopharma industry since 2007
- Access to
summary headline, upfront, milestone and royalty data
- Access to over
130 cancer symptoms contract documents
- The leading
cancer symptoms deals by value since 2007
Latest Reports:
Construction
in South Africa to 2017: Market Forecast: http://www.marketresearchreports.biz/analysis-details/construction-in-south-africa-to-2017-market-forecast
Timetrics
'Construction in South Africa to 2017: Market Forecast' contains detailed
historic and forecast market value data for the construction industry,
including a breakdown of the data by construction activity (new construction,
repair and maintenance, refurbishment and demolition). The databook provides
historical and forecast valuations of the industry using the construction
output and value-add methods.
Summary
This
report is the result of Timetrics extensive market research covering the
construction industry in South Africa. It contains detailed historic and
forecast market value data for the construction industry, including a breakdown
of the data by construction activity (new construction, repair and maintenance,
refurbishment and demolition). 'Construction in South Africa to 2017: Market
Forecast' provides a top-level overview and detailed insight into the operating
environment of the construction industry in South Africa. It is an essential
tool for companies active across the South Africannnn construction value chain
and for new players considering to enter the market.
Scope
- Overview of the
construction industry in South Africa.
- Historic and
forecast market value for the construction industry by construction output
and value-add methods for the period 2008 through to 2017.
- Historic and
forecast market value by construction activity (new construction, repair
and maintenance, refurbishment and demolition) across the construction
industry for the period 2008 through to 2017.
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are specially
designed to save time and money for our clients. We are a one stop solution for
all your research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve all
sizes and types of companies spanning across various industries.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
– Canada Toll Free: 866-997-4948
